Pamelor and Sucralfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pamelor (nortriptyline hydrochloride) and Sucralfate (sucralfate). Common drug interactions include maternal exposure during pregnancy among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Pamelor and Sucralfate. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Pamelor?

Pamelor has active ingredients of nortriptyline hydrochloride. It is often used in migraine. eHealthMe is studying from 4,069 Pamelor users. Check the latest studies of Pamelor.

What is Sucralfate?

Sucralfate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 17,548 Sucralfate users. Check the latest studies of Sucralfate.

On Aug, 11, 2026

18 people who take Pamelor and Sucralfate together, and have interactions are studied.

Pamelor and Sucralfate drug interactions.

What are the common drug interactions of Pamelor and Sucralfate, by gender? *:

female:

Maternal exposure during pregnancy (use of substance during pregnancy)
Iron deficiency anaemia
Premature delivery
Impaired gastric emptying
Intervertebral disc degeneration (spinal disc degeneration)
Irritable bowel syndrome
Renal failure (kidney dysfunction)
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Hypersensitivity
Pancreatitis chronic (chronic inflammation of pancreas)

male:

Chronic kidney disease
Renal failure (kidney dysfunction)
Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
Abdominal pain
Bladder cancer
Drug hypersensitivity
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
Premature baby
Nephrogenic anaemia (anaemia due to kidney disease)

What are the common drug interactions of Pamelor and Sucralfate, by age (0-1 to 60+)? *:

0-1:

Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
Premature baby

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)

40-49:

Chronic kidney disease
Premature delivery
Renal failure (kidney dysfunction)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Abdominal pain
Bladder cancer
Drug hypersensitivity
Pre-eclampsia (high blood pressure and significant amounts of protein in the urine of a pregnant woman)
Renal hypertension (high blood pressure caused by the kidneys hormonal response)
Renal tubular necrosis (death of kidney tubules)

50-59:

Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Hypersensitivity
Impaired gastric emptying
Intervertebral disc degeneration (spinal disc degeneration)
Irritable bowel syndrome
Pancreatitis chronic (chronic inflammation of pancreas)
Thyroid disorder (thyroid diseases)

60+:

Renal failure (kidney dysfunction)
Chronic kidney disease
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Bruxism (habitual grinding of the teeth, typically during sleep)
Burning sensation
Butterfly rash
Cataract (clouding of the lens inside the eye)
Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Chorea (abnormal involuntary movement disorder)
Colonic polyp (extra part of colon tissue grow in intestine)

What are the existing conditions these people have? *

Pain: 14 people, 77.78%
Depression: 11 people, 61.11%
High Blood Pressure: 9 people, 50.00%
Stress And Anxiety: 8 people, 44.44%
Rickets (softening of bones): 7 people, 38.89%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 38.89%
Diabetes: 7 people, 38.89%
Intestinal Obstruction: 7 people, 38.89%
High Blood Cholesterol: 5 people, 27.78%
Dizziness: 4 people, 22.22%

* Approximation only. Some reports may have incomplete information.

Do you take Pamelor and Sucralfate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously